Following WES, which identifies DNA variants, RNA-seq and, in some instances, mass spectrometry, have been used to identify the DNA variants that are tumor-expressed proteins and neoepitopes presented on MHC (2, 9, 12–14). This evidence concerns the gene HLA-C and neoplasm.